NPI: 1104010768 · WATERBURY, CT 06705 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/28/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/28/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,093 | $596K |
| 2019 | 29,608 | $295K |
| 2020 | 26,057 | $213K |
| 2021 | 19,289 | $185K |
| 2022 | 15,161 | $82K |
| 2023 | 6,399 | $64K |
| 2024 | 3,769 | $115.60 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,255 | 3,464 | $494K |
| 83970 | 2,244 | 1,969 | $315K | |
| 82728 | 1,472 | 1,292 | $166K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 39,433 | 2,168 | $99K |
| 83550 | 1,401 | 1,201 | $97K | |
| 83540 | 1,543 | 1,320 | $77K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,375 | 1,570 | $60K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,903 | 473 | $30K |
| 82108 | 162 | 155 | $27K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,156 | 759 | $22K |
| 85041 | 2,413 | 2,163 | $15K | |
| A4657 | Syringe, with or without needle, each | 2,597 | 2,321 | $13K |
| 85048 | 2,408 | 2,158 | $11K | |
| J1756 | Injection, iron sucrose, 1 mg | 8,257 | 1,943 | $9K |
| G0008 | Administration of influenza virus vaccine | 166 | 141 | $0.00 |
| 90674 | 41 | 32 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 18 | 12 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 438 | 251 | $0.00 |
| 90662 | 94 | 82 | $0.00 |